Earlier in May 2026, Pfizer reported positive Phase 2 results for its investigational 25‑valent pneumococcal conjugate vaccine in infants, showing strong immune responses versus PREVNAR 20 and ...
Coronavirus: Pfizer testing possible vaccine on 360 U.S. patients; what does that mean; what is mRNA
Pfizer pharmaceutical company announced this week that it has begun human trials for a vaccine for the COVID-19 virus. On Monday, Pfizer, along with Germany pharmaceutical company BioNTech, began ...
The race to greenlight a COVID-19 vaccine in the United States has entered its final sprint, with one leading candidate becoming the first to release preliminary results showing its vaccine is more ...
Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness.
A Roseland Community Hospital nurse prepares doses of the Pfizer vaccine on Dec. 30, 2021, during a COVID-19 vaccination event at Josephine's Southern Cooking in Chatham, Illinois. (Brian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results